vTv Therapeutics Inc expected to post a loss of 8  cents a share - Earnings Preview

vTv Therapeutics

30/04/2022 03:04

* vTv Therapeutics Inc  VTVT.OQ   VTVT.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 3
(estimated). 
    * ​Refinitiv's mean analyst estimate for vTv Therapeutics
Inc is
for a loss of 8 cents per share. For the same quarter last year,
the company reported a loss of 8 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for vTv
Therapeutics
Inc is $5​, above​ its last closing price of $0.69. ​​​

This summary was machine generated April 30 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated